Meanwhile, CD&R is seeking $26bn for its latest flagship fund, which would rank among the biggest raised in the buyout ...

By Sahil Pandey Oct 5 (Reuters) - Drug distributor McKesson and private equity firm Clayton Dubilier & Rice are nearing a deal to acquire infusion services provider Option Care Health in a transaction ...

Option Care is in advanced talks after a joint bid from McKesson and private equity firm Clayton Dubilier & Rice, FT reported ...

Shares of Option Care Health (NASDAQ: OPCH) surged 22% in after-hours trading on Monday following a Financial Times report that healthcare giant McKesson and private equity firm Clayton Dubilier & ...

Shares of McKesson Corp. rose 5.27% to $898.82 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.19% to 7,666.45 and the Dow ...

Business Wire said McKesson reaffirmed fiscal 2027 adjusted EPS guidance of USD 44.20-45.00 on October 1, 2026. Management ...

The fiscal 2027 guidance range centers on USD 44.60, only USD 0.05 below the USD 44.65 consensus cited by MarketBeat. That narrow gap makes execution against the outlook more important than a headline ...

McKesson just became the latest healthcare supplier to confirm a major data breach. Last week, in a filing with the U.S. Securities and Exchange Commission, the healthcare and pharmaceutical giant ...

Shares of healthcare distributor and services company McKesson jumped 4.4% in the afternoon session after the company reached ...

McKesson says confirmed data theft traces mainly to cancer and specialty practice customers. What patients should watch for ...

An August data theft at healthcare giant McKesson affected 6.4 million email addresses and potentially exposed patient health information. ShinyHunters claims it ...